Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 4 days ago

PolyPid Ltd.: Rosalind Advisors, Inc. amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 13 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Rosalind Advisors, Inc. amended its Schedule 13G beneficial ownership filing for PolyPid Ltd., per SEC accession 0001622627-26-000030. The filing updates the advisor's reported stake in the Israeli drug developer, though the amended document did not disclose a revised share count or percentage in the headline details. Schedule 13G amendments are typically filed when a passive investor's position crosses or moves past the 5% threshold or when previously reported holdings change materially. Investors will watch for the specific share total and ownership percentage in the full filing to gauge whether Rosalind increased or trimmed its position.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Rosalind Advisors, Inc., PolyPid Ltd.